This protein is secreted almost entirely into serum in both rats and mice, apparently via a consitutive or constitutive-like pathway

This protein is secreted almost entirely into serum in both rats and mice, apparently via a consitutive or constitutive-like pathway. Acknowledgments This work was supported by the Division of Intramural Research, National Institute of Dental and Craniofacial Research, National Institutes of Health. not appear to influence each other’s sorting behaviour. The Fc fragment showed a primarily basal localization, whereas growth hormone showed an SRPKIN-1 apical localization, in rat submandibular gland acinar cells. Conclusions The results obtained in the present study indicate that this mouse Fc fragment is usually a useful model protein for examining the basolateral versus apical secretory pathways employed by transgenic secretory proteins in salivary glands. Keywords: basolateral secretion, constitutive pathway, gene therapy, salivary glands, sorting Introduction Salivary glands have been proposed as suitable target organs for gene therapy [1,2]. Salivary glands are easily accessible by cannulation, are not critical for life and can produce large amounts of proteins. Salivary gland epithelial cells are polarized, and secretion from these cells into the saliva can occur in an exocrine manner [1,3] or basolaterally into the bloodstream [1,4]. Exocrine secretion can be used to deliver therapeutic proteins to the upper gastrointestinal tract, whereas the endocrine route can be utilized for systemic protein delivery. The route of secretion depends on how the protein of interest is usually sorted within salivary gland cells. SRPKIN-1 Salivary acinar cells exhibit two regulated secretory pathways (RSPs) [5]. The major RSP entails the storage of select cargo proteins in large dense-core granules, which are discharged in response to high doses of in salivary glands. You will find two different models to explain the selection of content proteins for storage in secretory granules [8]. According to the sorting-for-entry hypothesis, you will Rabbit Polyclonal to FZD9 find sorting signals on regulated proteins that are recognized by sorting receptors. To enter the forming secretory granule, a protein either has to be bound to a sorting receptor or it has to bind to other proteins that are already bound to the receptor. All other proteins are excluded from secretory granules. This sorting process takes place in the trans-Golgi network (TGN). The sorting-by-retention model, on the other hand, assumes that secreted proteins, unless directly or indirectly associated with the membrane, can freely enter the forming secretory granules, regardless of whether or not they are stored [8]. RSP proteins are retained and stored, whereas inefficiently stored proteins are then progressively removed from the maturing granules. According to this model, the immature secretory granule serves as an important post-TGN sorting station. Salivary gland acinar cells also exhibit secretory pathways that do not depend on extracellular activation [5]. The constitutive pathway originates in the TGN and transports nongranule proteins [6]. The constitutive-like pathway originates in maturing secretory granules, does not require stimulation, and carries proteins that are poorly retained in large secretory granules during maturation [5,6]. Constitutively secreted proteins can be sorted apically SRPKIN-1 or basolaterally [5]. Human erythropoetin (hEPO) is usually a constitutively secreted protein, physiologically produced in the kidney, which has been expressed in the salivary glands of mice [9C12] and rats [12C14]. Importantly, there SRPKIN-1 is a difference in the sorting of transgenic hEPO when expressed in rat and mouse submandibular glands [12]. When considering the total amount of transgenic protein produced, hEPO is usually secreted into serum at high levels in both species. However, whereas SRPKIN-1 very little transgenic hEPO is usually secreted into mouse saliva, in rat saliva, the concentration of hEPO is usually higher than it is in serum. Accordingly, the serum-to-saliva ratio of total secreted hEPO.